<DOC>
	<DOCNO>NCT01242566</DOCNO>
	<brief_summary>The management glioblastoma elderly patient poor performance status ( KPS &lt; 70 ) unsettle . This single arm phase 2 trial trial design evaluate efficacy safety temozolomide alone population</brief_summary>
	<brief_title>Temozolomide Elderly Patients With KPS &lt; 70</brief_title>
	<detailed_description>This trial conduct evaluate efficacy , term survival quality life , safety up-front temozolomide elderly GBM patient poor performance status . Patients 70 year age old eligible participate prospective non-randomised multicentric phase II study newly diagnose histologically proven glioblastoma basis WHO classification , postoperative KPS 30 60 . Treatment consist temozolomide 150-200 mg/m2/day 5 consecutive day every 4 week maximum 12 cycle disease progression prohibit toxicity . Patients assess least every month mean physical neurological examination , KPS , health-related EORTC questionnaire ( QLQ-C30 QLQ-BN20 ) , MMSE . Complete blood count blood chemistry drawn temozolomide cycle ; early also check every 10 day first 2 cycle every 2 week afterwards . CT MRI study repeat every 2 month .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Histologically confirm supratentorial glioblastoma Baseline contrastenhanced CT gadoliniumenhanced MRI study perform within first 4 day resection within first 4 week diagnostic biopsy Patients age 70 year old KPS 30 70 Life expectancy high 4 week Clinical examination baseline Affiliation Social Security mandatory beneficiary Patient inform obtention write informed consent Prior surgical resection date 1 month inclusion Prior brain radiotherapy chemotherapy Severe underlie disease could interfere survival History hypersensibility reaction temozolomide component Severe bone marrow hypoplasia Aspartate aminotransferase alanine aminotransferase 3 time upper limit normal Absolute neutrophil count &lt; 1.5x109 cell per liter Platelet count &lt; 100x109 cell per liter Hemoglobin &lt; 9 g/dl Neuroimaging baseline examination perform beyond first 4 day resection beyond first 4 week diagnostic biopsy</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Temozolomide</keyword>
	<keyword>Elderly</keyword>
	<keyword>Glioblastoma</keyword>
	<keyword>Karnofsky performance score ( KPS )</keyword>
</DOC>